HCG MANAVATA CANCER CENTRE ACHIEVES WORLD-FIRST IN ROBOTIC-ASSISTED (NSM) GROUNDBREAKING ADVANCEMENT IN BREAST CANCER SURGERY

Dr. Raj Nagarkar and his team at HCG Manavata Cancer Centre (HCGMCC) have made a groundbreaking advancement in breast cancer surgery by performing the world's first robotic-assisted nipple-sparing mastectomy (RNSM) using the Versius CMR system.

The surgery was conducted on a 35-year-old woman who was diagnosed with breast cancer in March 2024. Nipple-sparing mastectomy (NSM) traditionally involves removing the entire breast tissue while preserving the nipple, areola, and skin through a maximally invasive open surgical technique. However, the HCG Manavata team has pioneered a minimally invasive approach using robotic assistance, enhancing precision and dexterity with 3D visualization. This method ensures complete mastectomy without compromising oncological safety and significantly improves cosmetic outcomes.

“The patient underwent eight cycles of chemotherapy followed by surgery in July 2024. Due to her positive BRCA genetic mutation and family history of breast cancer, it was necessary to remove her entire breast and nodes, along with the opposite breast and ovaries. She was discharged on the third day after surgery,” says Dr Raj Nagarkar, MD & Chief of Surgical Oncology & Robotic Services, HCG Manavata Cancer Centre (HCGMCC).